Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00503867 · ClinicalTrials.gov registry record · NA
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
A NA study, sponsored by Sirtex Medical.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT00503867 is a NA study that was terminated before completion, run by Sirtex Medical. The registered enrollment target is 10 participants.
The verdict
NCT00503867, a NA study, was terminated before completion, sponsored by Sirtex Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The main purpose of this study is to determine the safety and toxicity of treatment with SIR-Spheres® in patients with unresectable primary liver cancer or hepatocellular carcinoma (HCC). Other purposes of this study include assessment of the effect of treatment on overall survival, the length of time it takes for the disease to worsen, if and how the treatment affects the patient's quality of life, and if and how the cancer responds to the treatment.
Interventions
- DEVICE SIR-Spheres microspheres
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-07-18 |
| Est. Completion | 2010-03-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00503867
The ClinicalTrials.gov registry entry for NCT00503867 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sirtex Medical, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SIR-Spheres microspheres is the first listed.
NCT00503867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00503867 about?
NCT00503867 is a clinical study titled "SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma". The main purpose of this study is to determine the safety and toxicity of treatment with SIR-Spheres® in patients with unresectable primary liver cancer or hepatocellular carcinoma (HCC). Other purposes of this study include assessment of the effect of treatment on overall survival, the length of ti...
What is the current status of trial NCT00503867?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2007-07-18. Estimated completion is 2010-03-09.
What interventions are being tested in trial NCT00503867?
The interventions under investigation include: SIR-Spheres microspheres (DEVICE).
Who is sponsoring clinical trial NCT00503867?
This trial is sponsored by Sirtex Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.